Workday To Rally Over 52%? Here Are 10 Top Analyst Forecasts For Thursday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have updated their outlooks on several companies, including Bread Financial, Ocular Therapeutix, KB Home, Shattuck Labs, Esperion Therapeutics, Workday, Taiwan Semiconductor Manufacturing, Meta Platforms, Citigroup, and Crocs. These updates include both upgrades and downgrades, with changes in price targets and ratings.
June 20, 2024 | 12:11 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Evercore ISI Group raised the price target for Bread Financial Holdings from $42 to $45 and upgraded the stock from Underperform to In-Line.
The upgrade and increased price target from a reputable analyst firm are likely to positively impact Bread Financial's stock in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
B of A Securities boosted Crocs' price target from $160 to $187 while maintaining a Buy rating.
The increased price target and maintained Buy rating suggest a positive outlook for Crocs, likely boosting its stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Evercore ISI Group increased KB Home's price target from $78 to $86 while maintaining an Outperform rating.
Maintaining an Outperform rating and increasing the price target indicates strong confidence in KB Home's future performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Keybanc increased Meta Platforms' price target from $475 to $540 while maintaining an Overweight rating.
The increased price target and maintained Overweight rating suggest a positive outlook for Meta Platforms, likely boosting its stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
TD Cowen raised the price target for Ocular Therapeutix from $7 to $11 and upgraded the stock from Hold to Buy.
The upgrade to Buy and significant increase in price target suggest a positive outlook for Ocular Therapeutix, likely boosting its stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Bernstein boosted the price target for Taiwan Semiconductor Manufacturing from $150 to $200 while maintaining an Outperform rating.
The significant increase in price target and maintained Outperform rating indicate strong confidence in TSM's future performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Baird boosted Workday's price target from $277 to $316 while maintaining an Outperform rating.
The increased price target and maintained Outperform rating suggest a positive outlook for Workday, likely boosting its stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Keefe, Bruyette & Woods raised Citigroup's price target from $66 to $69 while maintaining a Market Perform rating.
The modest increase in price target while maintaining a Market Perform rating suggests a neutral short-term impact on Citigroup's stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
B of A Securities slashed Esperion Therapeutics' price target from $2.9 to $2.5 and downgraded the stock from Neutral to Underperform.
The downgrade to Underperform and reduced price target are likely to negatively impact Esperion Therapeutics' stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
HC Wainwright & Co. cut the price target for Shattuck Labs from $28 to $16 but maintained a Buy rating.
The significant reduction in price target, despite maintaining a Buy rating, may create short-term negative sentiment around Shattuck Labs.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80